Advertisement
Advertisement

Switzerland buys Pfizer’s COVID-19 antiviral Paxlovid

By:
Reuters
Updated: May 20, 2022, 14:37 UTC

BERLIN (Reuters) - Switzerland signed a contract to buy Pfizer's anti-viral drug Paxlovid to treat Covid-19, it said on Friday.

Pfizer and MSD oral COVID-19 pills arrive at Misericordia hospital, in Grosseto

BERLIN (Reuters) – Switzerland signed a contract to buy Pfizer’s anti-viral drug Paxlovid to treat Covid-19, it said on Friday.

The European country said it had signed a contract to buy 12,000 packages and first treatments for certain at-risk patients would start this month.

(Reporting by Kirsti Knolle, Editing by Miranda Murray)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Did you find this article useful?

Advertisement